Each year, roughly 40,000 Indian men receive a prostate cancer diagnosis, most of them past 50, and many of them surprised — because the disease so often arrives without announcement. The body's quiet signals, the nightly bathroom trips and the weakening stream, are easy to dismiss as the ordinary tax of aging, yet they may carry a more urgent meaning. Doctors are asking men to resist that dismissal: to know their family histories, to notice patterns that persist, and to bring those observations into a conversation with a physician before silence becomes the disease's greatest advantage.
Men at 50: Don't dismiss prostate changes as aging, doctors warn
Early prostate cancer produces no symptoms. A man can carry it undetected for months or years.
Mark
So the article says 40,000 new cases a year in India. That's a lot. How many men over 50 are we talking about in the country?
Mimi
The article doesn't give that comparison, so we can't really know what percentage of men that represents. It's a concrete number, but without the denominator, it's hard to feel its true weight.
Luke
Right. And the article says "most of them in men past 50," but it doesn't break down how many are 50-60 versus 70-80. Age is a risk factor, but we don't know the actual distribution.
Mark
The doctor says early prostate cancer is often silent. How often? Is that 50 percent of cases, 90 percent?
Mimi
The article doesn't quantify it. Dr. Aggarwal says it "often" produces no symptoms and can "remain under the radar," but there's no data on prevalence.
Luke
That's a meaningful gap. "Often" could mean different things to different readers. Some might hear "most cases" and others might hear "occasionally." The reporting doesn't pin it down.
Mark
What about the PSA test? The article says it's not a cancer test in isolation. But how accurate is it? What's the false positive rate?
Mimi
The article explains that PSA rises for multiple reasons—enlargement, infection, inflammation—but it doesn't give numbers on how often a high PSA turns out to be cancer versus something benign.
Luke
That's critical information for a man deciding whether to get tested. The article tells him what PSA can't do, which is useful, but it doesn't tell him what it actually can do—the sensitivity, specificity, likelihood ratios. That's a real hole.
Mark
The article mentions family history of breast cancer in relatives. Is that a strong risk factor or a weak one?
Mimi
Dr. Aggarwal says it "may also provide an important clue" because some inherited genetic changes can increase risk. But he doesn't quantify how much it increases risk.
Luke
"May provide a clue" is pretty soft language. It's attributed to the doctor, so it's not invented, but the reader doesn't know if this is a major risk factor or a minor one. The reporting is honest about the uncertainty, but it leaves the reader without actionable information.
Mark
What about treatment outcomes? The article says early detection is "highly treatable." What does that mean in terms of survival rates?
Mimi
The article doesn't give survival statistics. It says treatment options include surveillance, surgery, or radiation, and that outcomes depend on grade, stage, PSA level, and health. But no numbers.
Luke
That's the most important thing a reader wants to know, and it's not there. "Highly treatable" is reassuring but vague. Five-year survival? Ten-year? Does it depend on the type of cancer? The article doesn't say.
The Pulse
- Prostate cancer kills quietly — early-stage disease produces no symptoms, allowing it to advance undetected for months or years while men assume they are simply growing older.
- The confusion deepens because benign prostate enlargement, inflammation, and cancer can all produce identical urinary symptoms, making self-diagnosis impossible and medical evaluation essential.
- Family history raises the stakes considerably — men with fathers, brothers, or female relatives who had prostate or certain breast cancers carry elevated genetic risk and need earlier, more deliberate conversations with their doctors.
- The PSA blood test offers a starting point but not an answer — its value lies in interpretation alongside symptoms and history, not as a standalone verdict.
- Early detection remains the clearest path to manageable treatment; once cancer spreads beyond the prostate, options narrow and complexity grows, making the timing of that first medical conversation consequential.
Each year, roughly 40,000 Indian men receive a prostate cancer diagnosis, most of them past 50, and many of them surprised — because the disease so often arrives without announcement. The body's quiet signals, the nightly bathroom trips and the weakening stream, are easy to dismiss as the ordinary tax of aging, yet they may carry a more urgent meaning. Doctors are asking men to resist that dismissal: to know their family histories, to notice patterns that persist, and to bring those observations into a conversation with a physician before silence becomes the disease's greatest advantage.
At 50, a man's body begins sending new signals — more frequent bathroom visits, a weaker stream, disrupted nights. These feel like the ordinary price of aging, and most men accept them as such. But urologists like Dr. Nitish Aggarwal of Fortis Healthcare in Chandigarh have spent careers watching men arrive too late, carrying a disease that had been growing in silence for years. Prostate cancer, which strikes around 40,000 Indian men annually, is defined by an early cruelty: it often produces no symptoms at all.
The prostate, a walnut-sized gland below the bladder, commonly enlarges with age — a benign condition called BPH. Prostatitis, an inflammation, can also develop. Both conditions mimic the urinary symptoms that cancer eventually produces: nightly urgency, a hesitant stream, blood in the urine. A man experiencing these changes cannot know which condition he carries without evaluation. What matters is not a single unusual night but a pattern that persists week after week.
Family history sharpens the picture. A father or brother with prostate cancer elevates a man's own risk. So does a close female relative with certain forms of breast cancer, since shared genetic mutations can increase prostate cancer vulnerability. Dr. Aggarwal urges men to know this history and bring it to their doctor — and for those with family connections to the disease, to have that conversation sooner rather than later.
The PSA blood test is the standard screening tool, but a single number diagnoses nothing. Elevated PSA can reflect an enlarged prostate, infection, inflammation, or cancer. Its meaning depends entirely on context — on symptoms, history, and a physician's interpretation. This is why blanket screening for every man over 50 remains debated, and why an individual conversation with a doctor is more valuable than any test result read in isolation.
The argument for taking all of this seriously is straightforward: prostate cancer caught while still confined to the gland responds well to treatment, whether through monitoring, surgery, or radiation. Once it spreads, the options narrow and the disease grows harder to manage. Dr. Aggarwal's message is not alarm — it is awareness. Notice what persists. Know your history. Do not let an uncomfortable conversation wait simply because the symptoms feel like aging. That gap between early detection and late discovery is where outcomes are decided.
At 50, a man's body sends new signals. The bathroom trips multiply, especially at night. The stream weakens. These changes feel inevitable, the price of getting older. But doctors want men to pause before accepting that story. Prostate cancer strikes roughly 40,000 Indian men each year, the vast majority past 50, and the disease has a particular cruelty: it often announces itself not at all.
Dr. Nitish Aggarwal, a urologist and uro-oncologist at Fortis Healthcare in Chandigarh, has spent his career watching men arrive at his clinic years after their prostate began its quiet rebellion. Early prostate cancer produces no symptoms. A man can carry it undetected for months or years while the cells multiply in silence. By the time urinary problems appear—frequent trips to the bathroom, a weak stream, blood in the urine—the cancer may have already begun its work. This is why the conversation matters now, before 50, not after.
The prostate itself is small, walnut-sized, sitting just below the bladder. It manufactures part of the fluid that carries sperm. With age, the gland commonly swells, a condition called benign prostatic hyperplasia, or BPH. This is not cancer. But here lies the trap: BPH, prostatitis (inflammation of the prostate), and prostate cancer can all produce nearly identical symptoms. A man experiencing nightly urination or difficulty starting his stream has no way to know which condition he carries without medical evaluation. The symptoms alone tell him nothing. What matters is persistence—not one unusual night, but a pattern that continues week after week.
This is where family history enters the picture. A man whose father or brother developed prostate cancer faces elevated risk. So does a man with close female relatives who had certain forms of breast cancer, because some inherited genetic mutations increase vulnerability to prostate cancer. Dr. Aggarwal emphasizes that men should know this history and bring it to their doctor. For those with family connections to the disease, the conversation should happen sooner, not later.
The PSA test—a blood measurement of prostate-specific antigen—has become the standard screening tool, but it carries its own complications. A single PSA reading diagnoses nothing. The number rises for multiple reasons: an enlarged prostate, infection, inflammation, or cancer. Without context, without a doctor's interpretation, a PSA result is merely a number. This is why routine screening for every man over 50 remains debated among physicians. The more useful approach is an individual conversation: a man and his doctor discussing his symptoms, his family history, what the tests can actually reveal, and what they cannot.
The stakes of this conversation are real. Prostate cancer caught early, while still confined to the gland, responds well to treatment. A man might pursue active surveillance, allowing the cancer to be monitored without immediate intervention. He might choose surgery or radiation therapy. The options depend on the cancer's grade and stage, his PSA level, his overall health, and his own preferences. But once cancer spreads beyond the prostate, the landscape changes. Treatment becomes more complex, options narrow, and the disease grows harder to manage. That gap—between early detection and late discovery—is the entire argument for taking persistent symptoms seriously.
Dr. Aggarwal's message is not alarmism. It is not a call for every man to fear prostate cancer or to demand screening at 50. It is a call for awareness. Know your family history. Notice whether your urinary habits have genuinely shifted and whether that shift persists. Understand what a PSA test can and cannot tell you. Do not assume that an uncomfortable conversation with a doctor can wait simply because the symptoms feel like ordinary aging. Lifestyle choices—weight, activity, tobacco, alcohol—matter for aggressive forms of the disease and for overall health. But they do not prevent prostate cancer. A prostate check-up is not about expecting bad news. It is about ensuring that an important part of men's health does not slip into silence until the disease has already advanced.
Notable Quotes
Early prostate cancer often causes no noticeable symptoms. That is one reason the disease can remain under the radar.— Dr. Nitish Aggarwal, Consultant Urologist & Uro-Oncologist, Fortis Healthcare, Chandigarh
A single PSA reading diagnoses nothing on its own. Levels rise for several reasons, including an enlarged prostate, infection, inflammation and other noncancerous conditions.— Dr. Nitish Aggarwal
Want the full story?
Read the original at The Times of India ↗